ANDA 71521, held by Sun Pharm Industries. Doxepin Hydrochloride.
As of Nov 16, 2026, ANDA 71521 (Doxepin Hydrochloride), held by Sun Pharm Industries, was first approved by FDA on Feb 18, 1988, with 9 approved supplements and 0 published complete response letters.
| Date | Submission | Status | Documents |
|---|---|---|---|
| Feb 18, 1988 | Original application | Approved | None posted |
| Product | Active ingredient | Marketing |
|---|---|---|
| Doxepin HydrochlorideEQ 100MG BASE · capsule;oral | Doxepin Hydrochloride | Discontinued |
| Jul 17, 2014 | Supplement 13Labeling · Standard review | Approved | None posted |
| Dec 1, 1998 | Supplement 12Manufacturing | Approved | None posted |
| May 6, 1996 | Supplement 11Labeling | Approved | None posted |
| Sep 26, 1995 | Supplement 10Labeling | Approved | None posted |
| Dec 23, 1994 | Supplement 9Manufacturing | Approved | None posted |
| Oct 11, 1994 | Supplement 8Manufacturing | Approved | None posted |
| Oct 1, 1993 | Supplement 7Labeling | Approved | None posted |
| Apr 3, 1992 | Supplement 6Manufacturing | Approved | None posted |
| Apr 3, 1992 | Supplement 4Manufacturing | Approved | None posted |
| Feb 18, 1988 | Original application | Approved | None posted |
Approvals, supplements, products and documents come from FDA's Drugs@FDA data files, refreshed daily; Drugs@FDA lists approved applications only. Complete response letters are FDA's published letters. Drugs@FDA and FDA complete response letters